Dr Maha Elbadri

Dr Maha Elbadri is a highly regarded Neurologist dedicated to providing comprehensive, compassionate care for individuals experiencing a broad range of neurological disorders. With an extensive background in managing both acute and chronic conditions of the central and peripheral nervous systems, Dr Elbadri approaches patient management with diligence, clinical rigour, and a strong emphasis on improving long-term quality of life.

Her primary area of clinical interest lies in complex and refractory epilepsy, with significant expertise in managing childhood-onset and adult-onset epileptic encephalopathies, including Lennox-Gastaut syndrome. Dr Elbadri is actively involved in implementing advanced pharmacological management strategies, such as adjunctive cannabidiol therapy, to assist patients whose seizures remain challenging to control through standard treatments. Her clinical scope encompasses a wide spectrum of neurological conditions, including Alzheimer's disease, amyotrophic lateral sclerosis (ALS), ataxia, Bell's palsy, brain tumours, cerebral aneurysms, acute spinal cord injuries, and traumatic brain injury.

Throughout her medical career, Dr Elbadri has maintained a strong commitment to clinical research and evidence-based medicine. She has contributed to peer-reviewed academic publications examining novel therapeutic interventions for complex seizure disorders and rare neurological presentations. As a dedicated Specialist, Dr Elbadri engages in ongoing professional development and multidisciplinary collaboration to ensure her patients receive precise diagnostic evaluations and personalised treatment plans tailored to their unique needs.